Crista Galli Ventures

Vitrue Health specializes in digital technology aimed at reducing musculoskeletal issues through accurate measurement and assessment. The company's flagship products, including VIDA and Vitrue EVVA, utilize advanced computer vision and biomechanics to objectively evaluate musculoskeletal health in various settings, from workplaces to clinical environments. VIDA specifically addresses the needs of desk workers by assessing their workspaces and ensuring compliance with ergonomic standards, helping to mitigate common problems like back and neck pain. Vitrue EVVA employs depth sensors for clinical-grade evaluations, which are valuable in orthopaedics, injury prevention in elite sports, and health screenings. By providing detailed reports and predictive insights regarding functional ability and core strength, Vitrue Health empowers both clinicians and patients to identify issues early, design optimal treatment plans, and engage patients in their recovery. The company’s mission is to establish a new foundation for musculoskeletal healthcare, aiming to alleviate pain and improve the quality of life for millions.

Jude is a healthcare company focused on addressing bladder-related issues and raising awareness about incontinence. It provides a range of bladder care solutions, including access to medical specialists who offer advice through social media platforms, virtual workshops, and private chat sessions. In addition to educational resources, Jude supplies health products designed to help individuals understand their conditions and manage them effectively. By promoting open discussions and providing expert guidance, Jude aims to empower individuals to lead leak-free lives and break the stigma surrounding bladder health.

Collective Minds Radiology is a cloud-based healthcare company specializing in radiology services that facilitate collaboration and consultation among medical professionals. The company provides a platform that enables radiologists to share imaging cases with peers and access expert advice, thereby enhancing the diagnostic process. Their innovative workspace integrates collective intelligence and artificial intelligence, allowing healthcare professionals to improve clinical audits and maintain high-quality standards in imaging. This approach supports the creation of a comprehensive reference library for enhanced analysis and promotes continuous education and research within the field of radiology.

Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

52 North Health is a medical technology company focused on enhancing healthcare outcomes for cancer patients. It specializes in an AI-driven, portable finger prick blood test that measures neutrophil count and C-reactive protein (CRP) levels at home. This enables early detection of neutropenic sepsis risk during chemotherapy, improving patient safety and quality of life. The device facilitates timely management of the condition, offering a reliable and cost-effective solution for both patients and healthcare providers.

Subtle Medical is a healthcare technology company that develops artificial‑intelligence software for magnetic resonance and positron emission tomography imaging. Its flagship products, SubtleMR and SubtlePET, are FDA‑cleared and CE‑marked tools that enhance image quality by reducing noise and sharpening detail, allowing scans to be performed faster and with lower radiation or contrast dose. The company’s deep‑learning algorithms integrate with any scanner without changing existing workflows, enabling imaging centers and hospitals to increase throughput and improve patient safety. Subtle Medical also offers a vendor‑agnostic AI platform that delivers analytics and support to clinical imaging providers. Founded in 2017 and headquartered in Menlo Park, California, the firm has received an NIH SBIR grant and an RSNA award for its GAD technology.

Surgery Hero is a pioneering digital prehabilitation clinic that focuses on preparing individuals for surgery and facilitating their recovery in the comfort of their homes. The company offers a digital care platform designed for surgery preparation, perioperative care, and post-operative recovery. By utilizing expert health coaches and providing digital guidance, Surgery Hero helps clients adopt lifestyle habits that are scientifically proven to enhance surgical outcomes. This approach not only optimizes both physical and mental readiness prior to surgery but also aims to reduce the risk of complications and accelerate the recovery process.

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

Adni is transforming the career management landscape for healthcare workers by offering an all-in-one AI-powered super app. This innovative platform streamlines various aspects of a healthcare worker's professional life, including job matching, credential updates, networking opportunities, and ongoing education. Adni's AI agents function as career copilots, assisting healthcare professionals in saving time and money. For employers, Adni provides a unique solution that not only facilitates recruitment from its extensive professional network but also focuses on talent retention. The platform enables healthcare organizations to create a customized engagement experience for clinicians, allowing them to access necessary resources, earn rewards, and find wellness support—all in one place. By prioritizing both recruitment and retention, Adni aims to foster a satisfied and engaged workforce in the healthcare sector.

Anja Health is a personalized, doctor-backed company specializing in umbilical cord blood and placenta stem cell banking. It offers a convenient service for expecting parents by providing a collection kit to facilitate the preservation of stem cells immediately after birth. Anja Health allows for up to two minutes of delayed cord clamping, ensuring that the collection of stem cells is performed safely. Once the birth occurs, parents can notify Anja's team using the contact number on the kit, prompting a medical courier to collect and swiftly transport the kit to a lab within 72 hours. The company aims to make the preservation of these vital stem cells both easy and affordable, empowering parents with knowledge about stem cell banking and its potential benefits for future medical treatments.

52 North Health is a medical technology company focused on enhancing healthcare outcomes for cancer patients. It specializes in an AI-driven, portable finger prick blood test that measures neutrophil count and C-reactive protein (CRP) levels at home. This enables early detection of neutropenic sepsis risk during chemotherapy, improving patient safety and quality of life. The device facilitates timely management of the condition, offering a reliable and cost-effective solution for both patients and healthcare providers.

Apryl is a platform that provides fertility benefits to employees, aiming to promote equality in the workplace.

Noula is a health technology company specializing in hormonal care. It empowers individuals with personalized insights derived from unique health data, including hormone biomarkers, genetics, nutrition, and lifestyle factors. Noula offers virtual support from clinicians to provide inclusive, whole-person care.

LEIA Health is a company that specializes in developing a postpartum support application for new parents. The app is designed to ease the transition into parenthood by offering personalized insights into both mental and physical health. It features medically validated information and tools that optimize health, including screening models for postpartum depression and pelvic floor complications. This enables women to identify potential risks at an earlier stage and connects them with appropriate healthcare providers. Through its innovative approach, LEIA Health aims to enhance the well-being of new parents during a critical period of their lives.

Charco Neurotech is a medical technology company focused on creating non-invasive wearable devices aimed at enhancing the quality of life for individuals with Parkinson's disease. The company's primary innovation involves a wearable device that modulates sensory dysfunction, which aids users in improving their movement speed and overall mobility. By addressing specific challenges faced by those living with Parkinson's, Charco Neurotech seeks to empower individuals to maintain a more active and normal lifestyle.

Sanome develops clinical decision support software that creates a real-time digital twin of an individual's health. The platform integrates with electronic health records to analyze clinical data and deliver explainable, regulated AI-enabled tools embedded in clinical workflows, helping healthcare providers identify emerging risks earlier and make faster, more accurate decisions as part of a proactive, preventive model of care. By combining artificial intelligence with diverse data streams, including at-home biomarker tests, the system translates information into actionable insights to support early detection and improved patient outcomes.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Parallel Health is a skin health company that uses genomics, the skin microbiome, and machine learning to offer end-to-end dermatology solutions. It develops a precision health platform that combines microbial genomics, big data, and AI to enable skin testing, personalized microbiome products, and custom prescriptions for consumers, patients, and clinicians, integrating derm telehealth, microbiome diagnostics, and data-driven skincare therapies to address diverse skin conditions with tailored treatments.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Radiobotics is a technology company focused on developing advanced machine learning algorithms that assist healthcare professionals in analyzing medical images, particularly x-rays of bones and joints. By automating routine tasks and generating radiology reports, the company's solutions facilitate quicker access to critical diagnostic information, thereby enhancing the quality of medical decision-making. Radiobotics aims to support doctors by streamlining the image analysis process, ultimately contributing to improved patient outcomes through more accurate and timely diagnoses.

Subtle Medical is a healthcare technology company that develops artificial‑intelligence software for magnetic resonance and positron emission tomography imaging. Its flagship products, SubtleMR and SubtlePET, are FDA‑cleared and CE‑marked tools that enhance image quality by reducing noise and sharpening detail, allowing scans to be performed faster and with lower radiation or contrast dose. The company’s deep‑learning algorithms integrate with any scanner without changing existing workflows, enabling imaging centers and hospitals to increase throughput and improve patient safety. Subtle Medical also offers a vendor‑agnostic AI platform that delivers analytics and support to clinical imaging providers. Founded in 2017 and headquartered in Menlo Park, California, the firm has received an NIH SBIR grant and an RSNA award for its GAD technology.

Radiobotics is a technology company focused on developing advanced machine learning algorithms that assist healthcare professionals in analyzing medical images, particularly x-rays of bones and joints. By automating routine tasks and generating radiology reports, the company's solutions facilitate quicker access to critical diagnostic information, thereby enhancing the quality of medical decision-making. Radiobotics aims to support doctors by streamlining the image analysis process, ultimately contributing to improved patient outcomes through more accurate and timely diagnoses.

Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Quibim is a global leader in whole-body medical imaging analysis headquartered in Valencia, Spain. Its platform, Quibim Precision, provides an AI-first ecosystem that standardizes imaging quality, automates feature extraction, and delivers quantitative imaging biomarkers across all body parts and modalities. The system integrates deep‑learning, radiomics, and multi‑omics data to enhance disease detection, support clinical trials, and monitor treatment efficacy for pharmaceutical companies and research teams worldwide.

Ampersand Health is focused on developing digital therapeutics for individuals with long-term inflammatory conditions. Based in London and incorporated in 2014, the company offers a comprehensive digital platform that includes the Ampersand Healthsuite, a management tool designed for patients, and Healthsuite for Clinicians, which supports clinician-led, patient-centered self-management. The platform utilizes behavioral science to deliver personalized therapy, featuring expert-led courses, self-management tracking, and clinical messaging. Ampersand Health aims to enhance patients' mental health and quality of life while also providing significant cost savings for healthcare providers by reducing overall healthcare utilization.

Vitrue Health specializes in digital technology aimed at reducing musculoskeletal issues through accurate measurement and assessment. The company's flagship products, including VIDA and Vitrue EVVA, utilize advanced computer vision and biomechanics to objectively evaluate musculoskeletal health in various settings, from workplaces to clinical environments. VIDA specifically addresses the needs of desk workers by assessing their workspaces and ensuring compliance with ergonomic standards, helping to mitigate common problems like back and neck pain. Vitrue EVVA employs depth sensors for clinical-grade evaluations, which are valuable in orthopaedics, injury prevention in elite sports, and health screenings. By providing detailed reports and predictive insights regarding functional ability and core strength, Vitrue Health empowers both clinicians and patients to identify issues early, design optimal treatment plans, and engage patients in their recovery. The company’s mission is to establish a new foundation for musculoskeletal healthcare, aiming to alleviate pain and improve the quality of life for millions.

Cerebriu is a health tech company that develops machine learning solutions for medical imaging to improve radiology workflow efficiency and diagnostic quality. Its artificial intelligence platform for magnetic resonance imaging accelerates image acquisition and enhances imaging speed and accuracy, increasing MRI accessibility by moving processing steps upstream in the workflow to enable timely diagnoses.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

Arthronica is a company developing an artificial intelligence-based platform for patient monitoring and rehabilitation, with a focus on arthritis and chronic rheumatic conditions. Its technology uses skeletal tracking, image analysis, and video analysis to monitor and predict key disease activities, supporting objective assessments of swelling and movement. The platform incorporates force-sensing vision and 3D CAD modeling to quantify physical changes and track disease progression for patients and practitioners. By enabling continuous monitoring and data-driven rehabilitation, Arthronica aims to improve clinical decision making and patient outcomes in musculoskeletal care. The company has conducted clinical trials in the United Kingdom and United States to validate its algorithms and system for real-world use.